Tag - monoclonal gammopathy of renal significance

  • Home
  • Tag -
  • monoclonal gammopathy of renal significance

ISN Journal summaries on MGRS risk prediction and CKD screening 

Kidney International®  The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy   Determining which patients with chronic kidney disease (CKD) and monoclonal gammopathy should undergo a kidney biopsy to diagnose monoclonal gammopathy of renal significance (MGRS) remains a clinical challenge.  Researchers developed and...

July 28, 2025Journals, NewsRead more...

New ISN Academy course: “Rare Kidney Diseases – MGRS and Amyloidosis”

The ISN Academy presents a comprehensive new course on monoclonal gammopathy of renal significance (MGRS) and amyloidosis, designed to equip healthcare professionals with critical knowledge on these rare but impactful conditions. Access the course here It features case-based, 20-minute recorded talks on key topics, including: The pathogenesis, diagnosis, and classification of MGRS subtypes—such as MIDD, PGNMID, C3G,...

March 10, 2025Education, ISN Toolkits, NewsRead more...